drugset / Trial / NCT00492011

Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers

NCT00492011

Phase 4 Completed 110 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study to determine the degree to which ramelteon, once daily (QD), can reduce the insomnia symptoms associated with rapid, eastward travel across 5 time zones.

Timeline

Start
2007-02
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 1 mg Oral
Subject Ramelteon Unknown 4 mg Oral
Subject Ramelteon Unknown 8 mg Oral